Evidence map›Paper›PMID 29380234›Full record

ArticleInternational journal of clinical pharmacy2018

Exploring the current and future role of the pharmacists in osteoporosis screening and management in Malaysia.

L S Toh, P S M Lai, S Othman, A Shah, C P L Dang, B Y Low, K T Wong, C Anderson

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

L S TohDivision of Pharmacy, School of Medicine, University of Tasmania, Sandy Bay Campus, Pharmacy Building Churchill Avenue, Tasmania, 7005, Australia. lishean.toh@utas.edu.au.ORCID http://orcid.org/0000-0002-9228-6266
P S M LaiUniversity of Malaya Primary Care Research Group (UMPCRG), Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
S OthmanUniversity of Malaya Primary Care Research Group (UMPCRG), Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
A ShahDivision of Pharmacy, School of Medicine, University of Tasmania, Sandy Bay Campus, Pharmacy Building Churchill Avenue, Tasmania, 7005, Australia.
C P L DangDivision of Pharmacy, School of Medicine, University of Tasmania, Sandy Bay Campus, Pharmacy Building Churchill Avenue, Tasmania, 7005, Australia.
B Y LowSchool of Pharmacy, University of Nottingham, Jalan Broga, 43500, Semenyih, Selangor, Malaysia.
K T WongSchool of Pharmacy, University of Nottingham, Jalan Broga, 43500, Semenyih, Selangor, Malaysia.
C AndersonDivision of Pharmacy Practice and Policy, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.
University of Tasmania · AUUniversity of Malaya · MYUniversity of Nottingham Malaysia Campus · MYUniversity of Nottingham · GB

Funding

Ministry of Science, Technology and Innovation (MOSTI) 06-02-12-SF0183
6 · The paper itself

Abstract

Background Several studies have found that pharmacists can assist in screening and prevention of osteoporosis by referring patients for bone mineral density scans and counselling on lifestyle changes. In Malaysia, screening osteoporosis in all elderly women is not mandatory due to its cost. One approach to address this gap is to develop a pharmacist-led osteoporosis screening and prevention program. However, there is a paucity of data on the perspectives of Malaysian pharmacists in this area. Objective To explore the perspective of stakeholders (policy makers, doctors, pharmacists, nurses and patients) towards the role of pharmacists in osteoporosis screening and management. Setting A primary care clinic located within a teaching hospital in Kuala Lumpur, Malaysia. Method Patients (n = 20), nurses (n = 10), pharmacists (n = 11), doctors (n = 10) and policy makers (n = 5) were individually interviewed using a semi-structured topic guide. Purposive sampling was used. Interviews were transcribed verbatim and analysed using thematic analysis. Main outcome measure Perspective of stakeholders on the current and future role of pharmacists. Results All participants perceived pharmacists to be suppliers of medication, although there was some recognition of roles in providing medication advice. Nonetheless, these stakeholders were eager for pharmacists to expand their non-dispensing roles towards counselling, creating awareness and screening of osteoporosis. Interviewed pharmacists referred to their current role as 'robotic dispensers' and unanimously agreed to spread out to osteoporosis management role. Conclusion Under stakeholders there is a willingness to expand the role of pharmacists in Malaysia to non-dispensing roles, particularly in osteoporosis screening and management.

Indexed as

Disease ManagementProfessional RoleAgedAttitude of Health PersonnelCounselingFemaleForecastingHospitals, TeachingHumansMalaysiaMaleMass ScreeningMiddle AgedOsteoporosisOutpatient Clinics, HospitalPharmacistsMalaysiaOsteoporosisPharmacist rolePostmenopausalQualitativeScreening

Identifiers

PMID29380234
OpenAlexW2786956113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.